Terms: = Prostate cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
1534 results:
1. Development and Validation of a Multimodality Model Based on Whole-Slide Imaging and Biparametric MRI for Predicting Postoperative Biochemical Recurrence in prostate cancer.
Hu C; Qiao X; Huang R; Hu C; Bao J; Wang X
Radiol Imaging Cancer; 2024 May; 6(3):e230143. PubMed ID: 38758079
[TBL] [Abstract] [Full Text] [Related]
2. prostate intra-fraction motion recorded by transperineal ultrasound.
Ballhausen H; Belka C; Li M
Sci Data; 2024 May; 11(1):504. PubMed ID: 38755158
[TBL] [Abstract] [Full Text] [Related]
3. On the necessity of specialized knowledge-based models for SBRT prostate treatments plans.
Scaggion A; Cavinato S; Dusi F; El Khouzai B; Guida F; Paronetto C; Rossato MA; Sapignoli S; Scott ASA; Sepulcri M; Paiusco M
Phys Med; 2024 May; 121():103364. PubMed ID: 38701626
[TBL] [Abstract] [Full Text] [Related]
4. [prostate cancer - from the patients' perspective].
Lewén K; Waller C; Grönberg H; Bratt O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38651688
[TBL] [Abstract] [Full Text] [Related]
5. Role of oxygen reserve index monitoring in patients undergoing robot-assisted radical prostatectomy: a retrospective study.
Ryu JH; Jeon YT; Sim KM; Lee S; Oh AY; Koo CH
World J Urol; 2024 Apr; 42(1):232. PubMed ID: 38613597
[TBL] [Abstract] [Full Text] [Related]
6. High-dose-rate Brachytherapy Monotherapy in Patients With Localised prostate cancer: Dose Modelling and Optimisation Using Computer Algorithms.
Dabic-Stankovic K; Rajkovic K; Stankovic J; Marosevic G; Kolarevic G; Pavicar B
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):378-389. PubMed ID: 38584072
[TBL] [Abstract] [Full Text] [Related]
7. Wireless electrostimulation for cancer treatment: An integrated nanoparticle/coaxial fiber mesh platform.
Resina L; Garrudo FFF; Alemán C; Esteves T; Ferreira FC
Biomater Adv; 2024 Jun; 160():213830. PubMed ID: 38552500
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant activated Notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse.
Kang JW; He JP; Liu YN; Zhang Y; Song SS; Xu QX; Wei SW; Lu L; Meng XQ; Xu L; Guo B; Su RW
Cell Mol Life Sci; 2024 Mar; 81(1):155. PubMed ID: 38538986
[TBL] [Abstract] [Full Text] [Related]
9. Contemporary Diagnostic Reporting for Prostatic Adenocarcinoma: Morphologic Aspects, Molecular Correlates, and Management Perspectives.
Muthusamy S; Smith SC
Adv Anat Pathol; 2024 May; 31(3):188-201. PubMed ID: 38525660
[TBL] [Abstract] [Full Text] [Related]
10. Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.
Zhang J; Li S; Zhang M; Wang Z; Xing Z
J Cell Mol Med; 2024 Apr; 28(8):e18227. PubMed ID: 38520207
[TBL] [Abstract] [Full Text] [Related]
11. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive prostate cancer and Survival.
Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
[TBL] [Abstract] [Full Text] [Related]
13. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
[TBL] [Abstract] [Full Text] [Related]
14. Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
PLoS One; 2024; 19(3):e0290617. PubMed ID: 38457424
[TBL] [Abstract] [Full Text] [Related]
15. Conformity of ChatGPT recommendations with the AUA/SUFU guideline on postprostatectomy urinary incontinence.
Pinto VBP; de Azevedo MF; Wroclawski ML; Gentile G; Jesus VLM; de Bessa Junior J; Nahas WC; Sacomani CAR; Sandhu JS; Gomes CM
Neurourol Urodyn; 2024 Apr; 43(4):935-941. PubMed ID: 38451040
[TBL] [Abstract] [Full Text] [Related]
16. [Bladder cancer Detected Incidentally by Cystoscopy before Radical prostatectomy].
Oshiro H; Shimizu Y; Nakayasu R; Yamaguchi R; Utsunomiya N; Kanamaru S
Hinyokika Kiyo; 2024 Feb; 70(2):39-43. PubMed ID: 38447943
[TBL] [Abstract] [Full Text] [Related]
17. Multiobjective tree-based reinforcement learning for estimating tolerant dynamic treatment regimes.
Song Y; Wang L
Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364801
[TBL] [Abstract] [Full Text] [Related]
18. Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning.
Kang Z; Zhao YX; Qiu RSQ; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y
Cancer Immunol Immunother; 2024 Feb; 73(3):41. PubMed ID: 38349474
[TBL] [Abstract] [Full Text] [Related]
19. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
[TBL] [Abstract] [Full Text] [Related]
20. Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy.
Dickhoff LRM; Scholman RJ; Barten DLJ; Kerkhof EM; Roorda JJ; Velema LA; Stalpers LJA; Pieters BR; Bosman PAN; Alderliesten T
Brachytherapy; 2024; 23(2):188-198. PubMed ID: 38296658
[TBL] [Abstract] [Full Text] [Related]
[Next]
